Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019
Marco Solmi(University of Ottawa), Samuele Cortese(King's College London), André F. Carvalho(Barwon Health), Minjin Song(Yonsei University), Michele Fornaro(New York Psychoanalytic Society and Institute), Michaël Maes(Chinese Academy of Medical Sciences & Peking Union Medical College), Christoph U. Correll(German Centre for Cardiovascular Research), Elena Dragioti(University of Ioannina), Lauri Tuominen(University of Ottawa), Georgios Seitidis(University of Ioannina), Synthia Guimond(Royal Ottawa Mental Health Centre), Dimitris Mavridis(Délégation Paris 5), Aroldo Dargél(University of Ottawa), Jae Il Shin(Yonsei University), Francesco Monaco
Cited by 499
Related Papers
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
|Molecular Psychiatry|2021|3.6k
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
|World Psychiatry|2011|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k